Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19821509rdf:typepubmed:Citationlld:pubmed
pubmed-article:19821509lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C0010346lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C0205081lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C1530889lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:19821509lifeskim:mentionsumls-concept:C1121637lld:lifeskim
pubmed-article:19821509pubmed:issue6lld:pubmed
pubmed-article:19821509pubmed:dateCreated2010-5-18lld:pubmed
pubmed-article:19821509pubmed:abstractTextTeduglutide, an analog of glucagon-like peptide-2 (GLP-2), is associated with trophic effects on gut mucosa. Its role in the treatment of active Crohn's disease (CD) was assessed in a pilot, randomized, placebo-controlled, double-blinded, dose-ranging study.lld:pubmed
pubmed-article:19821509pubmed:languageenglld:pubmed
pubmed-article:19821509pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19821509pubmed:citationSubsetIMlld:pubmed
pubmed-article:19821509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19821509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19821509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19821509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19821509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19821509pubmed:statusMEDLINElld:pubmed
pubmed-article:19821509pubmed:monthJunlld:pubmed
pubmed-article:19821509pubmed:issn1536-4844lld:pubmed
pubmed-article:19821509pubmed:authorpubmed-author:BuchmanAlan...lld:pubmed
pubmed-article:19821509pubmed:authorpubmed-author:BernsteinChar...lld:pubmed
pubmed-article:19821509pubmed:authorpubmed-author:KatzSeymourSlld:pubmed
pubmed-article:19821509pubmed:authorpubmed-author:FangJohn CJClld:pubmed
pubmed-article:19821509pubmed:authorpubmed-author:Abou-AssiSouh...lld:pubmed
pubmed-article:19821509pubmed:authorpubmed-author:Teduglutide...lld:pubmed
pubmed-article:19821509pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19821509pubmed:volume16lld:pubmed
pubmed-article:19821509pubmed:ownerNLMlld:pubmed
pubmed-article:19821509pubmed:authorsCompleteYlld:pubmed
pubmed-article:19821509pubmed:pagination962-73lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:meshHeadingpubmed-meshheading:19821509...lld:pubmed
pubmed-article:19821509pubmed:year2010lld:pubmed
pubmed-article:19821509pubmed:articleTitleTeduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.lld:pubmed
pubmed-article:19821509pubmed:affiliationDivision of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. a-buchman@northwestern.edulld:pubmed
pubmed-article:19821509pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19821509pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:19821509pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed